Clinverse, a provider of automated financial management technology solutions for clinical trials, has added John Musante as chief commercial officer. Musante brings more than 25 years of experience across industry sectors including health care, technology, and life sciences.
Previously, Musante was senior vice president, business development, at INC Research, where he led a team of account executives and participated in the structuring and execution of the company’s commercial strategy. He has held executive positions in both large and small pharmaceutical companies, such as GlaxoSmithKline and AcSentient, as well as at industry service providers that specialize in supply chain and clinical development, including Tompkins Associates.
“My time at a large, global CRO allowed me to realize the challenges and complexities of managing clinical trial finances,” said Musante. “Clinverse addresses those challenges, allowing sponsors and CROs to reduce workload and costs while improving transparency and control.”